Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
MEET - bought back @3.6 for a 32% discount.
The stock is way oversold here.
PCMI - bought more around 12.3
PCMI - PCM Announces Increase to Share Repurchase Program
GlobeNewswire•August 9, 2017
Board approves $10 Million increase to existing repurchase program
EL SEGUNDO, Calif., Aug. 09, 2017 (GLOBE NEWSWIRE) -- PCM, Inc. (PCMI), a leading technology solutions provider, today announced that its Board of Directors has approved an increase in the Company’s existing share repurchase program by an additional $10 million. The new authorization is in addition to the $4.1 million that was available for repurchase under previous Board authorizations, leaving the Company with $14.1 million available for repurchases under the program.
Brandon LaVerne, Chief Financial Officer, commented, “We continue to believe our shares are undervalued and, based on our current capital resources and the long-term outlook for our business, we see an opportunity to create value for our long-term shareholders.”
Purchases may be made from time to time in negotiated purchases or in the open market at prevailing market prices, including through Rule 10b5-1 prearranged stock trading plans designed to facilitate the repurchase of the Company's shares during times it would not otherwise be in the market due to self-imposed trading blackout periods or possible possession of material nonpublic information. We expect that the repurchase of our common stock under the program will be financed with existing working capital and amounts available under our existing credit facility, subject to any limitations therein. The timing and amounts of any such repurchases of shares will be subject to market conditions and certain other factors, and will be in accordance with applicable securities laws and other legal requirements. The repurchase program has no expiration date, does not require the purchase of any minimum number of shares and may be implemented, modified, suspended or discontinued in whole or in part at any time without further notice.
https://finance.yahoo.com/news/pcm-announces-increase-share-repurchase-212317493.html
PCMI - bought back @13.475
TIXC - you're not the only one. I also bought
it here. The big volume is because of one trade
of 605k shares @.45. Maybe it was the CEO buying
some of the "up to 2 million shares" he wants to buy.
ITEK - i made a few trades on it before the
phase 2 results were out. Was too risky to hold
through it.
I watched it to enter again after the collapse, but wanted
to see a few more days of consolidation.
Unfortunately, it ran from .90 to 1.05 without me.
Hopefully, it will hit your target in the next few days.
Good luck.
NEOT - i joined you in this one a few days
ago @.427 and sold today @.54-.548
Thanks RN.
Also sold ACRX today @3-3.1 from 2.35 entry.
ORV.TO - Orvana Reports Record Quarterly Gold Production in Q3 2017
https://finance.yahoo.com/news/orvana-reports-record-quarterly-gold-103000215.html
TORONTO, July 17, 2017 /PRNewswire/ - Orvana Minerals Corp. (ORV.TO) (the "Company" or "Orvana") is providing the following production results for the El Valle Mine ("El Valle") in Spain and Don Mario Mine ("Don Mario") in Bolivia for the third quarter of fiscal 2017 ("Q3 2017").
Record consolidated quarterly gold production of 26,414 ounces;
Consolidated gold equivalent production of 35,292 ounces in Q3 2017 representing an increase of 27% compared to Q2 2017;
On track to meet fiscal 2017 production guidance;
El Valle gold and copper production increased by 15% and 24%, respectively, compared to Q2 2017 due to higher recoveries and tonnes milled; mill throughput averaged 2,284 tonnes per day ("tpd") in the period;
Don Mario completed first full quarter of commercial production from the re-commissioned carbon-in-leach circuit ("CIL Circuit") achieving a 48% increase in gold production compared to Q2 2017 and gold recovery of 89.3%, exceeding target of 80%.
Production Highlights
Q3 2017
Q2 2017
YTD 2017
FY 2017
El Valle
Don Mario
Total
El Valle
Don Mario
Total
Total
Guidance
Operating Performance
Ore milled (tonnes) (dmt)
197,469
166,370
363,839
157,621
150,231
307,852
1,012,292
Gold Equivalent
Production (oz)
18,265
17,027
35,292
15,908
11,775
27,683
87,384
Gold
Grade (g/t)
2.35
2.66
2.49
2.60
2.50
2.55
2.33
Recovery (%)
91.9
89.3
90.6
90.4
71.1
81.2
82.5
Production (oz)
13,705
12,709
26,414
11,917
8,596
20,513
62,626
85,000 – 95,000
Copper
Grade (%)
0.53
0.79
0.65
0.58
0.75
0.66
0.72
Recovery (%)
80.2
68.3
73.7
74.1
54.6
63.7
64.0
Production ('000 lbs)
1,857
1,980
3,837
1,503
1,364
2,867
10,292
13,000 – 14,000
Silver
Grade (g/t)
11.69
5.40
8.81
13.49
5.48
9.58
10.81
Recovery (%)
75.0
68.8
73.3
74.7
58.2
70.1
71.2
Production (oz)
55,682
19,896
75,578
51,080
15,405
66,485
250,343
300,000 – 350,000
"The recent significant investments we have made into our operations are resulting in consistent quarter over quarter improvements in our production results. We are pleased to report the highest quarterly consolidated gold production in Orvana's history," said Jim Gilbert, Chairman and CEO. "With the improved gold production from the successful implementation of the CIL Circuit at Don Mario, we are well positioned to extend the life of Don Mario. At El Valle, the return to sustained higher mill throughput rates, in excess of our target of 2,000 tonnes per day, has allowed for higher metal production despite mining through lower grade skarn zones. We look forward to reporting Orvana's continued progress over the remainder of fiscal 2017."
Production – El Valle Mine
The El Valle and Carlés Mines produced 13,705 ounces of gold in Q3 2017, an increase of 15% compared to 11,917 ounces of gold produced in Q2 2017.
Copper production in Q3 2017 was 1.9 million pounds, compared to 1.5 million pounds in Q2 2017.
Mill throughput in Q3 2017 averaged 2,284 tpd, an increase of 24% compared to 1,844 tpd in Q2 2017 and in excess of target mill throughput rate of 2,000 tpd.
The increased metal production was primarily due to higher tonnes milled of 197,469 tonnes in Q3 2017 versus 157,621 tonnes in Q2 2017, as well as higher average recoveries, offset by lower head grades.
Production – Don Mario Mine
During Q3 2017, the first full quarter of commercial production for the CIL Circuit, Don Mario surpassed its targeted gold recovery rate of 80%. Gold production increased to 12,709 ounces, or 48% compared to 8,596 ounces of gold produced in Q2 2017. Gold production was also positively impacted by higher gold grades of 2.66 g/t in Q3 2017 versus 2.50 g/t in Q2 2017.
Copper production in Q3 2017 was 2.0 million pounds, compared to 1.4 million pounds in Q2 2017, primarily driven by an increase in copper recoveries of 25%.
About Orvana
Orvana is a multi-mine gold and copper producer. Orvana's operating assets consist of the producing gold-copper-silver El Valle and Carlés mines in northern Spain and the producing gold-copper-silver Don Mario mine in Bolivia. Additional information is available at Orvana's website (www.orvana.com).
MEET - sold @5.35 for 15% profit
ORV.v up another 8% today to 0.28 and almost
touched .30
The price around .20 was a joke and the stock
is still very cheap.
ORV.to - Finally breaking out today on big
volume. Currently up 15% to 0.265 and broke
through the 200 day MA @0.24
NAII - sold around 10.8 for a 25% gain. The stock
is overbought and is bouncing against the 200 day MA
which is currently @10.94.
MEET - bought @4.65
FNJN - they had a PR yesterday with Q1
results.
As i said in my previous post, i "Wanted to hold
through earnings on the 15th, but was surprised
to see it up 16% today, so i already sold @2."
Too bad. I knew the results would be excellent,
but knowing FNJN, i thought it will go down again
after the pump. But then another one came and the
stock never looked back.
With the spike after hours to around 2.8, it took FNJN
tons of good news (and pumps) to get to the level i sold
it almost two years ago! #msg-115960216
Since then, i traded it a few more times.
Congrats 2morrows and Great job holding it.
Don't forget to take profits.
Finjan Provides Shareholder Update for its Record First Quarter
of 2017:
https://finance.yahoo.com/news/finjan-provides-shareholder-record-first-203000664.html
FNJN - Thanks 2morrows. Nice close and volume
today. I hope it pulls back again soon, so i can
get in for another round.
FNJN - I told you that i might buy it
when it cools down #msg-130956566, so i did
on Friday before the close @1.72. Wanted to hold
through earnings on the 15th, but was surprised
to see it up 16% today, so i already sold @2.
I didn't find any news either. Maybe another promo.
PCMI - got out @20.45. Thanks nelson. While their
guidance probably takes this into consideration,
i don't like the fact that they didn't say anything
about this situation and didn't mention the lawsuits
in the PR. This is material information.
PCMI - i also bought @20.4 for (hopefully)
a bounce.
FNJN - 2morrows, i would be surprised if Israel
seed had something to do with the promo, but you
never know.
I might buy back after all the hype subsides
and the RSI, Stochastics, MACD and stock price
will go down.
FNJN up another 4% today on huge volume. They had
a paid promo yesterday that will last a few days.
This company was quiet for years and now all of the
sudden they have a PR blitz and paid (not by
the company) promotions.
Here is yesterdays promo:
We are Initiating Coverage of a Rapidly Growing Cyber Security Company Finjan Holdings, Inc. (NASDAQ: FNJN)
Good day traders,
We are looking at a company we feel is strong, with good near-mid term potential.
What do Ebay, Ashley Madison, Yahoo, Target, The DNC and JP Morgan Chase all have in common?
They have all had their electronic data compromised!
Every year one billion data records are compromised worldwide
60% of organizations report attackers infiltrated their systems in minutes
70-90% of malware samples collected were unique to the organization
Finjan Holdings, Inc. (NASDAQ: FNJN)
PROFITABLE WITH RAPID REVENUE GROWTH
Finjan Holdings, Inc., through its subsidiaries, operates as a cybersecurity company, providing intellectual property licensing and enforcement services.
The company owns a portfolio of patents related to software and hardware technologies that proactively detect malicious code and thereby protects end users from identity and data theft, spyware, malware, phishing, trojans, and other Web and network threats. Finjan’s proprietary technology focuses on proactively detecting threats to online security by identifying patterns and behavior of online viruses and other malicious code, rather than relying on lists of threats or "signatures" known within the online security industry. This technology allows users to scan and repel the latest, and often unknown, and sometimes polymorphic and metamorphic code threats to network, web, and endpoint security on a real-time proactive basis.
Finjan holds 28 U.S. patents and has 2 U.S. patents pending. All the patents can be viewed at: https://www.finjan.com/technology/patents
Finjan has generated more than $250M in income from the licensing of its intellectual property.
The company issued a press release last week announcing some Q1 financial results. According to Michael Noonan, Finjan CFO:
"Our $25 million in revenues during the first quarter of 2017, surpassed the $18.3 million in revenues for the full year in 2016. Our strong financial performance in 2016 and the first quarter of 2017 has enabled us to pay off our Series A Preferred financing in less than one year. This financial success is a testament to several years of implementing a focused IP licensing and enforcement strategy by our experienced team," said Michael Noonan, Finjan Holdings' CFO. "Looking ahead, we are on track to achieve full year profitability in 2017. With near-term litigation catalysts, a strong licensing pipeline, and recurring revenue through our Finjan Mobile subsidiary, we are well positioned for continued growth and positive cash flow. We look forward to providing shareholders with a more in-depth update after we file our 10Q for the period ending March 31, 2017."
(From 8-K filing dated April 25th, 2017) In other recent news, the company announced a new licensing agreement on April 25th. Its subsidiary Finjan, Inc. closed a Confidential Patent License Agreement with Avira Holding GmbH & Co. KG, a leading security software company that provides antivirus software, Internet Security, Privacy, Identity and Performance tools for computers, smartphones, servers, and networks, headquartered in Tettnang, Germany. The licensing deal is worth $4.9 million payable in 3 increments over the next 2 years.
Finjan's commitment to innovation in the security space continues through its investments which have culminated in the launch of Finjan’s consulting services business, CybeRisk, development of mobile applications through Finjan Mobile and incubation of up-and-coming technology startups pioneering a new generation of security technologies through investment in Jerusalem Venture Partners (JVP) Fund VII's Cyber Labs, having invested alongside other technology companies.
Finjan’s patented technologies are used in specific cyber security technology areas, including endpoint/cloud software, Web gateway/Internet infrastructure, networking equipment markets, and mobile security. The company’s technology scans and repels the latest and unknown threats to network, Web, and endpoint devices on a real-time basis. It also provides investments in cyber security technologies and intellectual property; offers cyber risk and cyber security advisory services; and develops mobile security applications. Finjan Holdings, Inc. was founded in 1997 and is headquartered in East Palo Alto, California.
Finjan Holdings, Inc. is rated by both Zacks Small Cap and B. Riley & Co. Both firms rate the shares a “Strong Buy” with a target price range of $2.75 - $7.78 and a consensus at $2.80 per share.
Finjan is in a dynamic, high growth industry. Their business model of deriving revenue through licensing of their patented technology gives them the unique advantage of a high gross profit margin. The company’s recent move into the mobile cyber security market may create a revenue catalyst in 2017. Given the analysts positive recommendations and the recent news about the huge leap in revenue during Q1, we feel these shares could be poised for good growth in the near-mid term.
Finjan Details and Highlights
Market cap- $43M
Shares outstanding- 23.14M
Shares in the float- 7.28M
Held by insiders- 52.43%
Held by institutions- 27.4%
Cash on hand (MRQ)- $13.68M
Quarterly revenue growth (YOY)- 110%
Gross Profit- 15.35M
EBITDA- 6.7M
Keep in mind these number are based on the most recent quarter filed and according to recent guidance issued by the company they are about to get even better.
Our coverage of Finjan (FNJN) will last at minimum, through the end of this week as we think there is a good possibility of very near term gains. We will also be watching FNJN’s quarterly reports in the coming weeks and months and will most likely have updates throughout 2017 and beyond.
The Team
DISCLAIMER
This website is a wholly owned subsidiary of Small Cap Specialists LLC, herein referred to as SCS LLC.
Our reports/releases are a commercial advertisement and are for general information purposes ONLY. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our services, joining our site or our email/blog list as well as any social networking platforms we may use.
PLEASE NOTE WELL: SCS LLC and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever.
Release of Liability: Through use of this website viewing or using you agree to hold SCS LLC, its operator’s owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. SCS LLC encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and SCS LLC makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead SCS LLC strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D. SCS LLC is compliant with the Can Spam Act of 2003. SCS LLC does not offer such advice or analysis, and SCS LLC further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk. It is possible that an investor’s investment may be lost or impaired due to the speculative nature of the companies profiled.
The Private Securities Litigation Reform Act of 1995 provides investors a ‘safe harbor’ in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be “forward looking statements”. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as “projects”, “foresee”, “expects”, “will”, “anticipates”, “estimates”, “believes”, “understands”, or that by statements indicating certain actions & quote; “may”, “could”, or “might” occur. Understand there is no guarantee past performance will be indicative of future results.
In preparing this publication, SCS LLC has relied upon information supplied by its customers, publicly available information and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this website. SCS LLC has been compensated fifteen thousand dollars cash via bank wire by third coast media for a two to three day investor relations and media services program for FNJN. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. The advertisements in this website are believed to be reliable, however, SCS LLC and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. SCS LLC is not responsible for any claims made by the companies advertised herein, nor is SCS LLC responsible for any other promotional firm, its program or its structure.
SCS LLC is not affiliated with any exchange, electronic quotation system, the Securities Exchange Commission or FINRA.
Copyright © 2017 Broad Street Alerts, All rights reserved.
ORVMF - I agree. The market cap is ridiculous,
especially with all the improvements they made
lately. Q2 will be much better than Q1, but Q3 & Q4
should be excellent.
I have been accumulating and bought a few blocks
around .16 before the latest PR and added another
50000 @.173 today.
Thanks KIK. Don't own any shares currently.
FNJN - yes, still following it and trading
it from time to time, including this year.
The problem with this one is that it can't hold
a gain and now it seems that Israel seed, which holds
more than 4.2 million shares is liquidating their position.
https://www.sec.gov/Archives/edgar/data/1107382/000117891317000999/xslF345X03/zk1719772.xml
STDY - up another 40% to over $8. More than
a triple in three months.
NAII - Natural Alternatives International, Inc. Announces Extension of CarnoSyn® beta-alanine Intellectual Property Portfolio
CARLSBAD, Calif., April 3, 2017 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, announced today that the U.S. Patent and Trademark Office has issued a Notice of Allowance of a patent application directed to a broad range of improved methods of beta-alanine intake. These 28 allowed patent claims target such benefits as delaying muscle fatigue, increasing anaerobic capacity, increasing muscle strength and increasing muscle endurance. This patent when issued will not only become part of NAI's extensive global portfolio covering its CarnoSyn® beta-alanine and SR CarnoSyn® product, but more importantly, significantly lengthens the patent coverage around its original CarnoSyn® beta-alanine to 2023. Following this Notice of Allowance NAI intends to seek a significant number of additional patent claims to further broaden its intellectual property protection.
Mark A. LeDoux, NAI's CEO and Chairman of the Board, said that "NAI is very excited by the addition of this important intellectual property related to a broad range of improved methods of beta-alanine intake. We believe this new patent continues to strengthen our worldwide portfolio of intellectual property related to our branded CarnoSyn® beta-alanine. Moreover, these patent rights will not expire until 2023, which gives NAI and its dedicated licensees the benefit of offering products that include CarnoSyn® beta-alanine and the patent portfolio surrounding it. These new patent rights further demonstrate our commitment and significant investment in the CarnoSyn® beta-alanine business."
NAI, headquartered in Carlsbad, California, is a leading formulator, manufacturer and marketer of nutritional supplements and provides strategic partnering services to its customers. NAI's comprehensive partnership approach offers a wide range of innovative nutritional products and services to NAI's clients including: scientific research, clinical studies, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management and support, packaging and delivery system design, regulatory review and international product registration assistance. For more information about NAI, please see its website at http://www.nai-online.com.
This press release contains forward-looking statements within the meaning of applicable securities laws that are not historical facts and information. These statements represent our intentions, expectations and beliefs concerning future events, including, among other things, our expectations and beliefs with respect to our intellectual property rights and the potential expansion thereof, the outcome of pending litigation, the continued validity of our patents, and our ability to successfully develop, license and enforce our intellectual property rights. We wish to caution readers these statements involve risks and uncertainties that could cause actual results and outcomes for future periods to differ materially from any forward-looking statement or views expressed herein. NAI's financial performance and the forward-looking statements contained herein are further qualified by other risks including those set forth from time to time in the documents filed by us with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q.
STDY - up 46% to 5.8 and over 120% from
where i posted about it in January.
They Received Favorable Ruling in their
Inter Partes Review against United Therapeutics:
http://finance.yahoo.com/news/steadymed-receives-favorable-ruling-inter-181917465.html
SPWH - sold @5 for a 16% gain. Bought for
a bounce and got it without the risk of holding
through earnings.
Good luck to those who still hold.
NSPR - sold half @1.05 for a 20% gain.
STDY - sold @4.1-4.4 in the last few
days for over 60% gain.
They have a catalyst in April that if successful,
can move the stock higher, but the stock is overbought
and what i made is good enough for me.
>>Obtaining a favorable ruling in our Inter Partes Review (IPR) challenge against U.S. Patent No. 8,497,393 (the '393 patent) owned by United Therapeutics Corporation in early Q2.<<
http://finance.yahoo.com/news/steadymed-outlines-strategic-goals-priorities-133000212.html
NSPR - bought @.87 for a bounce. Down from
around $2 after their recent offering.
http://finance.yahoo.com/news/dawson-james-securities-announces-completion-104500750.html
HLTH - sold @1.6
ITEK, NEOS - ITEK finally moving. Up 20%
on big volume.
NEOS keeps going up, now up 48% to 7.35 in a little
over a month.
NAII - bought back around 8.65. At this price
this is cheap enough even if it is dead money
for a while.
HLTH - bought @1.9
SCMP - sold @12.4 for a 12% gain.
SPWH sure sympathizes a lot. Almost every day since
the beginning of 2017...
SPWH - bought @4.3 and will give it a try here
for a bounce. This collapse is unbelievable.
The stock is down from 9.4 to 4.3 since the beginning
of the year without any news.
NEOS - sold @5.85 for 18% gain on the
bounce after their public offering.
AMPG - sold some more @.09 for a 350% gain.
This one is the stock that keeps on giving.
I sold some more yesterday @.077-.08 as it is
now a quadruple from my buys @.02 and below.